Inhibrx Biosciences (INBX) News Today $33.50 -1.46 (-4.18%) Closing price 04:00 PM EasternExtended Trading$33.36 -0.13 (-0.40%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INBX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Inhibrx Biosciences (NASDAQ:INBX) Hits New 52-Week High - What's Next?October 1, 2025 | marketbeat.comGoldman Sachs Group Inc. Sells 40,282 Shares of Inhibrx Biosciences, Inc. $INBXSeptember 29, 2025 | marketbeat.comAcadian Asset Management LLC Boosts Stake in Inhibrx Biosciences, Inc. $INBXSeptember 17, 2025 | marketbeat.comWoodline Partners LP Buys New Shares in Inhibrx Biosciences, Inc. $INBXSeptember 15, 2025 | marketbeat.comBluefin Capital Management LLC Acquires New Stake in Inhibrx Biosciences, Inc. $INBXSeptember 12, 2025 | marketbeat.comSlotnik Capital LLC Reduces Stock Position in Inhibrx Biosciences, Inc. $INBXSeptember 11, 2025 | marketbeat.comNuveen LLC Buys New Shares in Inhibrx Biosciences, Inc. $INBXSeptember 8, 2025 | marketbeat.comInhibrx Biosciences, Inc. $INBX Shares Sold by Deutsche Bank AGSeptember 3, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 27,315 Shares of Inhibrx Biosciences, Inc. $INBXSeptember 2, 2025 | marketbeat.comGroupe la Francaise Purchases New Position in Inhibrx Biosciences, Inc. $INBXAugust 27, 2025 | marketbeat.comInhibrx Biosciences Reports Q2 2025 Financial ResultsAugust 26, 2025 | tipranks.comInhibrx Biosciences' (INBX) "Market Perform" Rating Reiterated at JMP SecuritiesAugust 24, 2025 | marketbeat.comHighTower Advisors LLC Acquires 90,002 Shares of Inhibrx Biosciences, Inc. (NASDAQ:INBX)August 19, 2025 | marketbeat.comInhibrx Biosciences (NASDAQ:INBX) Upgraded by Wall Street Zen to Hold RatingAugust 18, 2025 | marketbeat.comInhibrx Biosciences (NASDAQ:INBX) Releases Earnings Results, Beats Estimates By $1.07 EPSAugust 15, 2025 | marketbeat.comInhibrx Biosciences, Inc.: Inhibrx Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | finanznachrichten.deXTX Topco Ltd Makes New Investment in Inhibrx Biosciences, Inc. (NASDAQ:INBX)August 14, 2025 | marketbeat.comInhibrx Reports Second Quarter 2025 Financial ResultsAugust 13, 2025 | prnewswire.comInhibrx Biosciences (INBX) Projected to Post Earnings on TuesdayAugust 6, 2025 | marketbeat.comInhibrx Biosciences Advances HexAgon-HN Study for Head, Neck CancerJuly 29, 2025 | msn.comTabor Asset Management LP Invests $506,000 in Inhibrx Biosciences, Inc. (NASDAQ:INBX)July 22, 2025 | marketbeat.comInhibrx Biosciences: Seeing Soon If The Momentum Is Just HypeJuly 18, 2025 | seekingalpha.comTabor Asset Management LP Takes $506,000 Position in Inhibrx Biosciences, Inc. (NASDAQ:INBX)July 18, 2025 | marketbeat.comNoteworthy Tuesday Option Activity: INBX, ODP, AZO | NasdaqJuly 10, 2025 | nasdaq.comInhibrx Biosciences (NASDAQ:INBX) Shares Up 8.7% - Still a Buy?July 9, 2025 | marketbeat.comINBX - Inhibrx Biosciences Inc Executives - MorningstarJuly 2, 2025 | morningstar.comMInhibrx Biosciences, Inc. (INBX) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comInhibrx Biosciences Inc (INBX) - Investing.comJune 25, 2025 | investing.comNuveen Asset Management LLC Makes New $385,000 Investment in Inhibrx, Inc. (NASDAQ:INBX)June 6, 2025 | marketbeat.comInhibrx, Inc. (NASDAQ:INBX) Shares Sold by Alpha Wealth Funds LLCJune 4, 2025 | marketbeat.comDeutsche Bank AG Takes $302,000 Position in Inhibrx, Inc. (NASDAQ:INBX)June 1, 2025 | marketbeat.comMillennium Management LLC Buys Shares of 258,388 Inhibrx, Inc. (NASDAQ:INBX)May 31, 2025 | marketbeat.comAlpha Wealth Funds LLC Buys New Stake in Inhibrx, Inc. (NASDAQ:INBX)May 29, 2025 | marketbeat.com116,104 Shares in Inhibrx, Inc. (NASDAQ:INBX) Acquired by Northern Trust CorpMay 28, 2025 | marketbeat.comJane Street Group LLC Buys New Shares in Inhibrx, Inc. (NASDAQ:INBX)May 22, 2025 | marketbeat.comSanofi Takes $17.83 Million Position in Inhibrx, Inc. (NASDAQ:INBX)May 19, 2025 | marketbeat.comLaird Norton Wetherby Wealth Management LLC Invests $472,000 in Inhibrx, Inc. (NASDAQ:INBX)May 18, 2025 | marketbeat.comInhibrx Biosciences, Inc.: Inhibrx Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deInhibrx Reports First Quarter 2025 Financial ResultsMay 14, 2025 | prnewswire.comCaption Management LLC Takes $3.08 Million Position in Inhibrx, Inc. (NASDAQ:INBX)May 8, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Makes New Investment in Inhibrx, Inc. (NASDAQ:INBX)May 8, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Purchases Shares of 160,899 Inhibrx, Inc. (NASDAQ:INBX)May 6, 2025 | marketbeat.comBoothbay Fund Management LLC Takes Position in Inhibrx, Inc. (NASDAQ:INBX)May 4, 2025 | marketbeat.comMarshall Wace LLP Takes $825,000 Position in Inhibrx, Inc. (NASDAQ:INBX)May 3, 2025 | marketbeat.comCastalian Partners LLC Purchases Shares of 191,533 Inhibrx, Inc. (NASDAQ:INBX)May 2, 2025 | marketbeat.comGeode Capital Management LLC Invests $3.93 Million in Inhibrx, Inc. (NASDAQ:INBX)April 29, 2025 | marketbeat.comBirchview Capital LP Acquires Shares of 32,110 Inhibrx, Inc. (NASDAQ:INBX)April 28, 2025 | marketbeat.comCredit Industriel ET Commercial Makes New $989,000 Investment in Inhibrx, Inc. (NASDAQ:INBX)April 26, 2025 | marketbeat.comCigogne Management SA Purchases New Holdings in Inhibrx, Inc. (NASDAQ:INBX)April 26, 2025 | marketbeat.com54,345 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Russell Investments Group Ltd.April 23, 2025 | marketbeat.com Get Inhibrx Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INBX Media Mentions By Week INBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INBX News Sentiment▼0.000.55▲Average Medical News Sentiment INBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INBX Articles This Week▼12▲INBX Articles Average Week Get the Latest News and Ratings for INBX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Inhibrx Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Dyne Therapeutics News Vera Therapeutics News Sarepta Therapeutics News Apogee Therapeutics News Intellia Therapeutics News Harrow News Aurinia Pharmaceuticals News Immunocore News Edgewise Therapeutics News Twist Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INBX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
